Mr. Speaker, we quickly realized early on in the pandemic that we needed to invest in flexible domestic production and upgrade our facilities. That is exactly what we did.
In fact, we had already taken significant steps in that direction before the pandemic. In our first term, we gave Innovation, Science and Economic Development Canada the means to invest in life sciences. Since the beginning of the pandemic, we have only accelerated our investments significantly by making large investments in production capacity, like Medicago and the National Research Council of Canada in Montreal.